We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+42.64%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$1.46B
AUM Growth
+$256M
Cap. Flow
+$4.95B
Cap. Flow %
338.44%
Top 10 Hldgs %
14.04%
Holding
1,230
New
412
Increased
195
Reduced
230
Closed
293

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.9B
2
NVRO
NEVRO CORP.
NVRO
+$76.5M
3
KBR icon
KBR
KBR
+$44.6M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$27.1M
5
BMRG.U
B. Riley Principal Merger Corp. II Units, each consisting of one share of Class A common stock and o
BMRG.U
+$9.88M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$46.4M
2
PHYS icon
Sprott Physical Gold
PHYS
+$21M
3
SPPP
Sprott Physical Platinum and Palladium Trust
SPPP
+$11.4M
4
HHHHW
Wealthbridge Acquisition Limited Warrants
HHHHW
+$10.2M
5
JIH
Juniper Industrial Holdings, Inc.
JIH
+$8.97M

Sector Composition

Rank Sector Weight
1 Technology 11.56%
2 Consumer Discretionary 8.68%
3 Healthcare 7.6%
4 Communication Services 6.73%
5 Industrials 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GARS
876
DELISTED
Garrison Capital Inc.
GARS
$88K 0.01%
+26,133
New +$64.2K
LJPC
877
DELISTED
La Jolla Pharmaceutical Company
LJPC
$88K 0.01%
20,620
+2,220
+12% +$13.5K
PVLA
878
Palvella Therapeutics
PVLA
$1.99B
$87K 0.01%
352
+17
+5% +$3.98K
AVID
879
DELISTED
Avid Technology Inc
AVID
$82K 0.01%
11,235
+535
+5% +$3.53K
OBSV
880
DELISTED
ObsEva SA Ordinary Shares
OBSV
$81K 0.01%
13,821
– –
BRPAR
881
DELISTED
Big Rock Partners Acquisition Corp. Right
BRPAR
$80K 0.01%
287,077
– –
STXS icon
882
Stereotaxis
STXS
$126M
$79K 0.01%
17,640
+840
+5% +$3.4K
SXC icon
883
SunCoke Energy
SXC
$720M
$78K 0.01%
26,250
+3,850
+17% +$12.3K
YARW
884
Yarrow Bioscience, Inc. Common Stock
YARW
$23.4M
$78K 0.01%
+13
New +$88K
NPKI
885
NPK International
NPKI
$1.06B
$76K 0.01%
34,125
+1,625
+5% +$2.75K
FCRD
886
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$76K 0.01%
+23,570
New +$69.9K
CLDT
887
Chatham Lodging
CLDT
$622M
$75K 0.01%
+12,300
New +$82.4K
KIN
888
DELISTED
Kindred Biosciences, Inc.
KIN
$75K 0.01%
16,610
+6,410
+63% +$28.6K
TFFP
889
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$72K ﹤0.01%
501
-126
-20% -$15.9K
KOS icon
890
Kosmos Energy
KOS
$1.6B
$70K ﹤0.01%
+41,934
New +$67.3K
ANVS icon
891
Annovis Bio
ANVS
$74.4M
$65K ﹤0.01%
+15,000
New +$62K
VRA icon
892
Vera Bradley
VRA
$97M
$63K ﹤0.01%
14,280
+680
+5% +$3.38K
ATEC icon
893
Alphatec Holdings
ATEC
$1.46B
$62K ﹤0.01%
13,090
-4,010
-23% -$17.7K
TOTAR
894
DELISTED
Tottenham Acquisition I Limited Right expiring 3/6/2021
TOTAR
$60K ﹤0.01%
200,000
– –
BTU icon
895
Peabody Energy
BTU
$2.6B
$58K ﹤0.01%
20,160
-12,440
-38% -$41.1K
BXRX
896
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$57K ﹤0.01%
10
-7
-41% -$33.6K
MCRB icon
897
Seres Therapeutics
MCRB
$46.8M
$55K ﹤0.01%
+580
New +$50.9K
XERS icon
898
Xeris Biopharma Holdings
XERS
$1.39B
$51K ﹤0.01%
19,190
+7,390
+63% +$25.7K
ALDX icon
899
Aldeyra Therapeutics
ALDX
$92.9M
$50K ﹤0.01%
12,075
+575
+5% +$2.1K
LTRPA
900
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$49K ﹤0.01%
22,995
-165,668
-88% -$378K
34 35
36
37 38

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return

Boothbay Fund Management's Q2 2020 Portfolio in Review

As of Q2 2020, Boothbay Fund Management held 1,230 positions worth $1.46B, up 21% from $1.21B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Boothbay Fund Management deployed $4.95B of net new capital in Q2 2020, opening 412 new positions and adding to 195 existing holdings. Its largest new stake was Tesla: 90,556,950 shares worth $25.6M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Sprott Physical Platinum and Palladium Trust, an estimated $11.4M trimmed.

  • Boothbay Fund Management's largest Q2 2020 buy was Tesla: 90,556,950 shares worth $25.6M.
  • Boothbay Fund Management added most to Alphabet (Google) Class C in Q2 2020, an estimated $27.1M increase.
  • Boothbay Fund Management's biggest Q2 2020 reduction was Sprott Physical Platinum and Palladium Trust, cutting an estimated $11.4M.
  • Boothbay Fund Management fully exited Allergan plc in Q2 2020, selling an estimated $46.4M.
  • Boothbay Fund Management's ten largest holdings make up 14% of its $1.46B portfolio in Q2 2020.
  • Boothbay Fund Management opened 412 new positions and closed 293 in Q2 2020.
  • Boothbay Fund Management's portfolio value rose 21% quarter-over-quarter to $1.46B.

Based on Boothbay Fund Management's 13F filing for Q2 2020, filed 14 Aug 2020.